Lerner SP - Search Results

1

New imaging techniques for nonmuscle invasive bladder cancer.

von Rundstedt FC, Lerner SP. von Rundstedt FC, et al. Among authors: lerner sp. Curr Opin Urol. 2014 Sep;24(5):532-9. doi: 10.1097/MOU.0000000000000093. Curr Opin Urol. 2014. PMID: 25051025 Review.

2

Adenovirus-mediated suicide gene therapy for experimental bladder cancer.

Sutton MA, Berkman SA, Chen SH, Block A, Dang TD, Kattan MW, Wheeler TM, Rowley DR, Woo SL, Lerner SP. Sutton MA, et al. Among authors: lerner sp. Urology. 1997 Feb;49(2):173-80. doi: 10.1016/S0090-4295(96)00560-2. Urology. 1997. PMID: 9037277

3

Current status of gene therapy for prostate and bladder cancer.

Herman JR, Lerner SP. Herman JR, et al. Among authors: lerner sp. Int J Urol. 1997 Sep;4(5):435-40. doi: 10.1111/j.1442-2042.1997.tb00281.x. Int J Urol. 1997. PMID: 9354942 Free article. Review. No abstract available.

4

Retinoids in the chemoprevention of bladder cancer.

Sabichi AL, Lerner SP, Grossman HB, Lippman SM. Sabichi AL, et al. Among authors: lerner sp. Curr Opin Oncol. 1998 Sep;10(5):479-84. doi: 10.1097/00001622-199809000-00019. Curr Opin Oncol. 1998. PMID: 9800121 Review.

5

Prognostic value of P53 nuclear accumulation and histopathologic features in T1 transitional cell carcinoma of the urinary bladder.

Shariat SF, Weizer AZ, Green A, Laucirica R, Frolov A, Wheeler TM, Lerner SP. Shariat SF, et al. Among authors: lerner sp. Urology. 2000 Nov 1;56(5):735-40. doi: 10.1016/s0090-4295(00)00756-1. Urology. 2000. PMID: 11068290

6

E-cadherin expression predicts clinical outcome in carcinoma in situ of the urinary bladder.

Shariat SF, Pahlavan S, Baseman AG, Brown RM, Green AE, Wheeler TM, Lerner SP. Shariat SF, et al. Among authors: lerner sp. Urology. 2001 Jan;57(1):60-5. doi: 10.1016/s0090-4295(00)00892-x. Urology. 2001. PMID: 11164145

7

E-cadherin immunostaining of bladder transitional cell carcinoma, carcinoma in situ and lymph node metastases with long-term followup.

Byrne RR, Shariat SF, Brown R, Kattan MW, Morton RA JR, Wheeler TM, Lerner SP. Byrne RR, et al. Among authors: lerner sp. J Urol. 2001 May;165(5):1473-9. J Urol. 2001. PMID: 11342899

8

Preoperative plasma levels of interleukin-6 and its soluble receptor predict disease recurrence and survival of patients with bladder cancer.

Andrews B, Shariat SF, Kim JH, Wheeler TM, Slawin KM, Lerner SP. Andrews B, et al. Among authors: lerner sp. J Urol. 2002 Mar;167(3):1475-81. J Urol. 2002. PMID: 11832773

9

Urinary levels of urokinase-type plasminogen activator and its receptor in the detection of bladder carcinoma.

Casella R, Shariat SF, Monoski MA, Lerner SP. Casella R, et al. Among authors: lerner sp. Cancer. 2002 Dec 15;95(12):2494-9. doi: 10.1002/cncr.10989. Cancer. 2002. PMID: 12467062 Free article.

10

Plasma levels of insulin-like growth factor-1 and binding protein-3, and their association with bladder cancer risk.

Zhao H, Grossman HB, Spitz MR, Lerner SP, Zhang K, Wu X. Zhao H, et al. Among authors: lerner sp. J Urol. 2003 Feb;169(2):714-7. doi: 10.1097/01.ju.0000036380.10325.2a. J Urol. 2003. PMID: 12544349

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

355 results

Search Page

Filters